Skip to main content

and
  1. Article

    Open Access

    Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases

    The aim of this study was to determine the safety and efficacy of fractionated stereotactic radiotherapy (SRT) in combination with systemic therapies (ST) for brain metastases (BM).

    Morgan Guénolé, François Lucia, Vincent Bourbonne, Gurvan Dissaux in BMC Cancer (2020)

  2. No Access

    Article

    Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab

    Cetuximab, a chimeric monoclonal antibody against EGFR sensitizes tumors to radiotherapy (RT), but is associated with skin and mucosal toxicity.

    Julien Roman, Gurvan Dissaux, Maelenn Gouillou, Yves Gobel in Targeted Oncology (2017)